Home › Respiratory Tract Infections › Idaho › Boise
Respiratory Tract Infections clinical trials in Boise, ID
3 studies for Respiratory Tract Infections are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Boise
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Humphreys Diabetes Center, Boise
- St. Luke's Idaho Elks Children's Pavilion, Boise
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- St. Luke's Humphreys Diabetes Center, Boise
- St. Luke's Children's, Boise
- St. Luke's Elks Children's Pavilion, Boise
Respiratory Tract Infections trials in other cities
- Hialeah, FL4 studies
- Pittsburgh, PA4 studies
- Washington, DC4 studies
- Houston, TX4 studies
- Dallas, TX4 studies
- Durham, NC3 studies
- Salt Lake City, UT3 studies
- Columbus, OH3 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colon Cancer7 studies
- Colorectal Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Breast Cancer6 studies
- Melanoma6 studies
- Burkitt Lymphoma5 studies
- Pancreatic Cancer4 studies
- Myeloproliferative Neoplasms4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.